XML 97 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity (Tables)
 12 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Equity Plans for the fiscal year ended September 30, 2019:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2018
69,980

 
$4.74
 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
(208
)
 
$3.97
 
 
 
—

Forfeited
(2,199
)
 
$4.16
 
 
 
 
Expired
(15,719
)
 
$3.97
 
 
 
 
Outstanding as of September 30, 2019
51,854

 
$5.00
 
4.79
 
$
0

Exercisable as of September 30, 2019
41,200

 
$5.07
 
4.43
 
$
0

Vested and expected to vest as of September 30, 2019
51,854

 
$5.00
 
4.79
 
$
0


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the fiscal year ended September 30, 2018, the intrinsic value of options exercised was $23,000.
Schedule of Restricted Stock Activity
The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the fiscal year ended September 30, 2019:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
1,011,621

 
$6.04
 
8,154

 
$8.20
Granted
 
752,416

 
$3.68
 
—

 
$0.00
Vested
 
(321,335
)
 
$5.94
 
—

 
$0.00
Forfeited
 
(443,455
)
 
$5.22
 
—

 
$0.00
Non-vested as of September 30, 2019
 
999,247

 
$4.66
 
8,154

 
$8.20
Schedule of Performance Share Activity
The following table summarizes the activity related to PSUs and PRSAs for the fiscal year ended September 30, 2019:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
397,777

 
$8.48
 
33,333

 
$12.25
Granted
 
280,000

 
$5.19
 
—

 
$0.00
Vested
 
(30,874
)
 
$7.14
 
—

 
$0.00
Forfeited
 
(175,079
)
 
$7.36
 
—

 
$0.00
Non-vested as of September 30, 2019
 
471,824

 
$7.03
 
33,333

 
$12.25
Schedule of Stock-based Compensation Expense - By Award Type
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the Fiscal Years ended September 30,
(in thousands)
2019
 
2018
 
2017
Employee stock options
$
25

 
$
32

 
$
45

Restricted stock units and awards
1,495

 
1,742

 
1,643

Performance stock units and awards
685

 
1,343

 
1,367

Employee stock purchase plan
180

 
276

 
300

Outside director equity awards and fees in common stock
221

 
255

 
247

Total stock-based compensation expense
$
2,606

 
$
3,648

 
$
3,602
Schedule of Stock-based Compensation Expense - By Expense Type
Stock-based Compensation Expense - by expense type
For the Fiscal Years ended September 30,
(in thousands)
2019
 
2018
 
2017
Cost of revenue
$
482

 
$
450

 
$
492

Selling, general, and administrative
1,478

 
2,584

 
2,605

Research and development
646

 
614

 
505

Total stock-based compensation expense
$
2,606

 
$
3,648

 
$
3,602
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net loss per share:

Basic and Diluted Net Loss Per Share
 
For the Fiscal Years ended September 30,
(in thousands, except per share)
 
2019
 
2018
 
2017
Numerator:
 
 
 
 
 
 
   (Loss) income from continuing operations
 
$
(35,984
)
 
$
(17,453
)
 
$
8,221

Undistributed (loss) earnings allocated to common shareholders for basic and diluted net (loss) income per share
 
(35,984
)
 
(17,453
)
 
8,235

Denominator:
 
 
 
 
 
 
Denominator for basic and fully diluted net (loss) income per share - weighted average shares outstanding
 
27,983

 
27,266

 
26,659

Dilutive options outstanding, unvested stock units, unvested stock awards and ESPP
 
—

 
—

 
885

Denominator for diluted net (loss) income per share - adjusted weighted average shares outstanding
 
27,983

 
27,266

 
27,544

 
 
 
 
 
 
 
Net (loss) income per basic and fully diluted share
 
$
(1.29
)
 
$
(0.64
)
 
$
0.31

 
 
 
 
 
 
 
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
810

 
949

 
398

 
 
 
 
 
 
 
Average market price of common stock
 
$
3.91

 
$
5.87

 
$
8.92
Schedule of Common Stock Reserved for Future Issuances
As of September 30, 2019, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
51,854

Unvested restricted stock units and awards
1,007,401

Unvested performance stock units and awards (at 200% maximum payout)
1,010,314

Purchases under the employee stock purchase plan
543,731

Issuance of stock-based awards under the Equity Plans
2,753,829

Purchases under the officer and director share purchase plan
88,741

Total reserved
5,455,870